Capital Guardian Trust’s Boston Scientific BSX Stock Holding History

Capital Guardian Trust’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,856	Closed	-$110K	–	289
2018 Q3	$110K	Buy	+2,856	New	+$99.8K	﹤0.01%	259
2017 Q2	–	Sell	-1,818	Closed	-$45K	–	251
2017 Q1	$45K	Hold	1,818	–	–	﹤0.01%	432
2016 Q4	$39K	Hold	1,818	–	–	﹤0.01%	471
2016 Q3	$43K	Hold	1,818	–	–	﹤0.01%	446
2016 Q2	$42K	Hold	1,818	–	–	﹤0.01%	448
2016 Q1	$34K	Hold	1,818	–	–	﹤0.01%	463
2015 Q4	$34K	Sell	1,818 -1,212	-40%	-$21.7K	﹤0.01%	481
2015 Q3	$50K	Hold	3,030	–	–	﹤0.01%	436
2015 Q2	$54K	Hold	3,030	–	–	﹤0.01%	438
2015 Q1	$54K	Buy	3,030 +1,212	+67%	+$19.2K	﹤0.01%	447
2014 Q4	$24K	Sell	1,818 -165	-8%	-$2.11K	﹤0.01%	442
2014 Q3	$23K	Buy	1,983 +165	+9%	+$2.08K	﹤0.01%	458
2014 Q2	$23K	Buy	+1,818	New	+$23.6K	﹤0.01%	435

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return

Capital Guardian Trust's BSX Position: Q4 2018 in Review

Capital Guardian Trust sold out of Boston Scientific (BSX) in Q4 2018, closing a stake of 2,856 shares — an estimated $110K sold.

Capital Guardian Trust first reported a position in BSX in Q2 2014 and held it in 13 quarters. The position peaked at $110K in Q3 2018. 731 funds tracked by Wall St. Rank hold BSX as of Q4 2018.

Capital Guardian Trust reported no remaining Boston Scientific position as of Q4 2018 after selling out during the quarter.
Capital Guardian Trust sold 2,856 Boston Scientific shares in Q4 2018, an estimated $110K.
Capital Guardian Trust first reported a position in Boston Scientific in Q2 2014 and held it in 13 quarters.
Capital Guardian Trust's Boston Scientific position peaked at $110K in Q3 2018.
731 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2018.

Based on Capital Guardian Trust's 13F filing for Q4 2018, filed 14 Feb 2019.